VABYSMOⓇ (faricimab-svoa)

Read the VABYSMO Indications and Important Safety Information below and full Prescribing Information at bit.ly/VABPI

A big THANK YOU to everyone who attended #AAO2024. It was a great event and we hope you had as much fun as we did. START FIRST WITH VABYSMO Learn more here: https://lnkd.in/dX3PnqRz Read the full Prescribing Information here: bit.ly/VABPI Intended for US healthcare professionals only.

Looking to learn more about health inequities in retina and what you can do to address them? Join Dr. Coney for Genentech’s ‘Evolving Equitable Care’ talk at AAO 2024 October 19, 11:30 AM CST and discover actionable solutions to drive change and increase equitable access at the local level. Learn how other retina specialists are partnering together to address health inequities here: bit.ly/47aaXWO. And make sure to visit Genentech booth #3408 at AAO 2024. #VABYSMO #nAMD #Genentech #Ophthalmology Read the full Prescribing Information here: bit.ly/VABPI Intended for US healthcare professionals only.

Why are leading retina experts calling #VABYSMO a ‘game changer’? Hear Drs. Amy Babiuch, Krishna Mukkamala and Jeremy Wolfe discuss the flexibility of 1–4 month dosing* for their patients and practice. Hear more from the experts here: https://bit.ly/4euRDqm #faricimab #amd #dme #ophthalmology *In nAMD and DME after 4 or 6 monthly (DME only) loading doses. Monthly dosing for 6 months in RVO. See additional dosing information at https://lnkd.in/eCnXNiUj Dr. Amy Babiuch – Cleveland Clinic Cole Eye Institute Dr. Sri Krishna Mukkamala – Georgia Retina, PC, EyeSouth Partners Dr. Jeremy Wolfe – Associated Retinal Consultants, P.C., EyeCare Partners Read the full PI here: bit.ly/VABPI Intended for US Healthcare Professionals only.

Have you heard? The VABYSMO Prefilled Syringe is here. Deliver the difference within. ∼90% of patients are covered to start VABYSMO as their first branded treatment*. PFS NDC Codes. Same J-Code. Discover more here:  https://lnkd.in/eBgjfDVQ Read the full VABYSMO Prescribing Information here: bit.ly/VABPI Intended for U.S healthcare professionals only. *Coverage determined for VABYSMO vial based on Medicare Fee for Service and tracking of the largest payers for other books of business. Bevacizumab (not indicated for intraocular use) and biosimilars are excluded from the branded treatment category. Specific coverage may vary for individuals and plans. Data as of January 2024.

We hope you’ve been enjoying our LinkedIn posts, but we want to make them even better! #faricimab #VABYSMO

How is #VABYSMO changing the landscape of DME and nAMD treatment? Hear Drs. Amy Babiuch, Krishna Mukkamala, and Jeremy Wolfe consider why the majority* of retina specialists across the US have started using dual-pathway VABYSMO. Hear more from the experts here: https://lnkd.in/eNdQkJdb *Data on file. #faricimab #amd #dme #ophthalmology Dr. Amy Babiuch – Cleveland Clinic Cole Eye Institute Dr. Krishna Mukkamala – Georgia Retina, PC and EyeSouth Partners Dr. Jeremy Wolfe – Associated Retina Consultants, PC and EyeCare Partners Read the full PI here: bit.ly/VABPI Intended for US Healthcare Professionals only.

Discover the POWER 2 OPEN your patients’ world. Read the full Prescribing Information here: bit.ly/VABPI Intended for US healthcare professionals only.

We’re thrilled to share an important update to help your practice prescribe VABYSMO with confidence. ~90% of patients are covered to start VABYSMO as their first branded treatment* Explore more access resources on our website to START NOW with dual-pathway VABYSMO: https://lnkd.in/e5SSEzV3 Read the full PI: bit.ly/VABPI Intended for US healthcare professionals only.

95% of Retina Specialists would use VABYSMO for their loved one.* This Father’s Day, three Retina Specialists (Dr. Joseph Coney, Retina Associates of Cleveland, Inc.; Dr. Esther Kim, Orange County Retina; Dr. Steve Couvillion, California Retina Consultants) share some of dad’s wisdom that they carry with them in their practice every day. *For nAMD; in a survey of 56 Retina Specialists. Read the full Prescribing Information here: bit.ly/VABPI Intended for US healthcare professionals only.